Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction
Warren S. Alexander(Walter and Eliza Hall Institute of Medical Research), Douglas J. Hilton(Walter and Eliza Hall Institute of Medical Research), Steven Rakar(Walter and Eliza Hall Institute of Medical Research), Manuel Baca(Tri-Institutional Therapeutics Discovery Institute), Tracy A. Willson(Walter and Eliza Hall Institute of Medical Research), Benjamin T. Kile(Discovery Institute), Rachael T. Richardson(Bionics Institute), Robyn Starr(Walter and Eliza Hall Institute of Medical Research), Sandra Mifsud(The Royal Melbourne Hospital), Sandra E. Nicholson(Walter and Eliza Hall Institute of Medical Research), Marta Brysha(The Royal Melbourne Hospital), Alison Farley(Walter and Eliza Hall Institute of Medical Research), Ladina DiRago(The Royal Melbourne Hospital), Jason Corbin(Walter and Eliza Hall Institute of Medical Research), Nicos A. Nicola(The Royal Melbourne Hospital), Andrew G. Elefanty(The Royal Melbourne Hospital), Elizabeth M. Viney(The Royal Melbourne Hospital), Jian‐Guo Zhang(Nantong University), Dale Cary(Walter and Eliza Hall Institute of Medical Research), Donald Metcalf(Walter and Eliza Hall Institute of Medical Research), Naomi S. Sprigg(Walter and Eliza Hall Institute of Medical Research)
Cited by 115
Related Papers
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor.
|The EMBO Journal|1989|699
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
|Proceedings of the National Academy of Sciences|1999|632
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
|Proceedings of the National Academy of Sciences|2000|465